XZWE:XETRA:XETRA-Xtrackers MSCI World ESG UCITS ETF 2C - EUR Hedged (EUR)

ETF | Others |

Last Closing

USD 71.6

Change

+0.79 (+1.12)%

Market Cap

USD 0.31B

Volume

1.01K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-0.91 (-1.97%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.61 (+0.61%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.51 (-2.11%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.12 (-0.89%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.06 (-1.16%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.20 (-0.85%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.12 (+0.93%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.11 (-0.19%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.12 (+1.20%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.07 (+0.06%)

USD 12.26B

ETFs Containing XZWE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.57% 48% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.57% 51% F 48% F
Trailing 12 Months  
Capital Gain 9.46% 75% C 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.46% 76% C+ 73% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 10.99% 71% C- 70% C-
Dividend Return 10.99% 70% C- 68% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.14% 50% F 60% D-
Risk Adjusted Return 90.54% 80% B- 82% B
Market Capitalization 0.31B 61% D- 46% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike